Evidence map›Paper›PMID 41703976›Full record

ArticleCancer reports (Hoboken, N.J.)2026

The Impact of Time Interval to Surgery After Neoadjuvant Chemoradiotherapy on Oncological Outcomes: A Long-Term Follow-Up Study on Rectal Cancer Patients.

Marzieh Rahimi, Mohammadreza Mamaghani-Ghazijahani, Fatemeh Shahabi, Majid Ansari, Mahdie Ghiyasi Noei, Mina Alvandipour, Abbas Abdollahi

Abstract read
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marzieh RahimiEndoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0001-7855-0123
Mohammadreza Mamaghani-GhazijahaniEndoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0009-0001-2353-6727
Fatemeh ShahabiEndoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0001-7840-170X
Majid AnsariEndoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0002-8383-3555
Mahdie Ghiyasi NoeiEndoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0009-0000-6775-9837
Mina AlvandipourDepartment of Surgery, Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran.ORCID 0000-0003-4131-798X
Abbas AbdollahiEndoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0001-6834-5759

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeoadjuvant chemoradiotherapy (nCRT) has been shown to improve prognosis in patients with locally advanced rectal cancer (LARC). However, there is still debate regarding the optimal time of surgery following nCRT.

aimsThis exploratory study aimed to investigate whether there is a difference in oncological outcomes between patients with LARC who undergo surgery within 6 weeks of nCRT and those who wait longer than 6 weeks. METHODS AND

resultsThis retrospective study included patients with rectal tumors who underwent nCRT followed by laparoscopic surgery during 2011-2020. Based on the time interval, the study participants were divided into two groups: ≤ 6 weeks and > 6 weeks. Receiver Operating Characteristics and Kaplan-Meier survival curves were employed to evaluate the effect of time interval on overall survival (OS) and recurrence-free survival (RFS). Cox regression analysis was used to identify the prognostic factors of RFS and OS. A total of 175 patients were included in our study with a mean ± SD age of 56.1 ± 12.9 years. The median (interquartile range) follow-up time was 71 (63) months. There was no difference in demographic and clinical variables between the two groups. Neither pCR, OS, nor RFS was affected by the nCRT-surgery interval. Multivariable Cox regression analysis showed that patients with ypStage III had a mortality and recurrence hazard of 7.6 and 3.3 times higher than those with pCR (p < 0.001, p = 0.018, respectively). Additionally, those who underwent abdominoperineal resection (APR) were 5.8 times more at risk of developing recurrence (p = 0.001).

conclusionThe present study revealed that pCR rates, OS, and RFS were not affected by the nCRT-surgery interval within the cohort studied. In addition, the time interval of more than 6 weeks may be safe, as no substantial difference in postoperative complications was observed between groups. The ypTNM staging was an independent predictor of OS and RFS. Moreover, APR was considered an important prognostic factor for RFS. These findings require further investigation by multicenter, large-scale studies in the future.

Indexed as

Chemoradiotherapy, AdjuvantNeoadjuvant TherapyNeoplasm Recurrence, LocalProctectomyRectal NeoplasmsTime-to-TreatmentAgedFemaleFollow-Up StudiesHumansLaparoscopyMaleMiddle AgedPathologic Complete ResponsePrognosisRetrospective Studiesintervalneoadjuvant chemoradiotherapyrectal cancerrecurrencesurgerysurvival

Identifiers

PMID41703976
PMCPMC12914080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.